Finding Cancer, Creating Solutions, Saving Lives.

Copyright © 2010 Cangen Biotechnologies, Inc. All Rights Reserved.

Cangen Biotechnologies is a start up biotechnology company focusing on genetic techniques for the detection and treatment of cancer. Johns Hopkins developed a technology for detection of cancer called Micro Satellite Analysis and exclusively licensed this technology to Cangen.  Micro Satellite Analysis or MSA finds patient DNA affected by cancer at a very early stage of the disease.  Cangen has applied this technology for the detection of Bladder and Lung cancers.

For more information please contact Cangen using the Contact Us tab above.